Vaccine adjuvants based on TLR receptor ligands
Lipidated oxoadenines of formula (I) are TLR7/8 receptor ligands useful for modulating immune responses. The compounds may have therapeutic application in the treatment of cancer, infectious diseases, allergy, or autoimmune disorders.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
23.04.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Lipidated oxoadenines of formula (I) are TLR7/8 receptor ligands useful for modulating immune responses. The compounds may have therapeutic application in the treatment of cancer, infectious diseases, allergy, or autoimmune disorders. |
---|---|
Bibliography: | Application Number: US202318446041 |